Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2021

349  The University of Texas Rio Grande Valley  (84645)

Principal Investigator: Chauhan, Subhash

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 50,000

Exceeds $250,000 (Is it flagged?): No

Start and End Dates: 1/1/21 - 12/31/21

Restricted Research: YES

Academic Discipline: N/A

Department, Center, School, or Institute: Immunology and Microbiology

Title of Contract, Award, or Gift: Co-delivery of K-RasG12D inhibiting siRNA and miR-145 mimic for PDAC treatment

Name of Granting or Contracting Agency/Entity: Kosten Foundation Pancreatic Cancer Rese

CFDA: N/A

Program Title: N/A

Note:

In this application, we will develop a nanoparticle formulation for the pancreatic tumor specific delivery of miR-145 and K-Ras inhibiting siRNA and investigate if this formulation effectively inhibits oncogenic mechanisms involved in tumor growth, metastasis, and drug resistance of PDAC. This project would establish that combination therapies could be delivered through our nanotechnology platform that selectively target PDAC tumor and macro/micro metastatic lesions with minimum toxicities upon systemic administration. Overall, this proposal is designed to enable in-depth pre-clinical studies along with the investigations on the mechanisms. This proposal has potential to develop a new therapeutic modality for pancreatic cancer especially those became resistant to frequently used chemotherapies such as gemcitabine.

Discussion: No discussion notes

 

Close Window